R&D Women in life sciences: Why female representation still lags... pharmaphorum spoke with Sheila Diamond, director of scientific engagement at Medidata, about being a woman in STEM.
Patients The unmentionables: Challenging inequalities in women’s heal... As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, bu
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
